statistiche ricercatore

Continente	#
NA - Nord America	607
AS - Asia	520
EU - Europa	322
SA - Sud America	74
AF - Africa	36
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.562

Nazione	#
US - Stati Uniti d'America	591
SG - Singapore	211
VN - Vietnam	110
CN - Cina	105
IE - Irlanda	74
BR - Brasile	53
IT - Italia	53
SE - Svezia	51
HK - Hong Kong	41
DE - Germania	40
FR - Francia	28
ZA - Sudafrica	21
NL - Olanda	16
GB - Regno Unito	14
CZ - Repubblica Ceca	12
AR - Argentina	8
CA - Canada	8
FI - Finlandia	8
IN - India	8
IQ - Iraq	7
PH - Filippine	5
RU - Federazione Russa	5
BD - Bangladesh	4
CI - Costa d'Avorio	4
ES - Italia	4
PK - Pakistan	4
BE - Belgio	3
EG - Egitto	3
IR - Iran	3
JP - Giappone	3
LT - Lituania	3
MX - Messico	3
TR - Turchia	3
AL - Albania	2
BO - Bolivia	2
CO - Colombia	2
EC - Ecuador	2
HR - Croazia	2
ID - Indonesia	2
IL - Israele	2
KR - Corea	2
KZ - Kazakistan	2
MA - Marocco	2
PL - Polonia	2
PY - Paraguay	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
BG - Bulgaria	1
CG - Congo	1
CH - Svizzera	1
CL - Cile	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GP - Guadalupe	1
GY - Guiana	1
JM - Giamaica	1
JO - Giordania	1
LB - Libano	1
LV - Lettonia	1
MY - Malesia	1
NG - Nigeria	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
QA - Qatar	1
RS - Serbia	1
SA - Arabia Saudita	1
SN - Senegal	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.562

Nome	#
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers	145
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing	144
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study	137
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer	132
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study	129
A wide skull osteolytic metastasis in advanced breast cancer	117
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer	113
Retroperitoneal cystoadenocarcinoma: A case report with a literature review	106
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents	105
Effectiveness and safety of “real” concurrent stereotactic radiotherapy and immunotherapy in metastatic solid tumors: a systematic review	98
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review	92
Chemotherapy in metastatic renal cell carcinoma today? A systematic review	89
Colony-stimulating factors for febrile neutropenia [7]	87
Drug-induced megaloblastic anemia	86
Totale	1.580

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1	0	0	0	0	0	0	0	0	0	0	0	1
2021/2022	40	0	0	5	0	1	1	8	2	1	0	1	21
2022/2023	264	20	32	18	18	31	33	2	14	88	1	5	2
2023/2024	121	6	14	1	2	3	15	9	6	5	15	29	16
2024/2025	363	18	18	31	20	34	39	5	22	41	41	34	60
2025/2026	741	104	58	82	62	105	68	57	31	107	67	0	0
Totale													1.580